Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · IEX Real-Time Price · USD
6.69
+0.38 (5.94%)
Apr 19, 2024, 4:00 PM EDT - Market closed
Lifecore Biomedical Income Statement
Financials in millions USD. Fiscal year is June - May.
Millions USD. Fiscal year is Jun - May.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 103.27 | 111.27 | 100.87 | 160.07 | 557.56 | 524.23 | 469.78 | 476.92 | 539.26 | 476.81 | Upgrade
|
| Revenue Growth (YoY) | -7.19% | 10.31% | -36.98% | -71.29% | 6.36% | 11.59% | -1.50% | -11.56% | 13.10% | 7.95% | Upgrade
|
| Cost of Revenue | 75.28 | 72.2 | 61.94 | 120.68 | 476.56 | 445.89 | 390.56 | 410.14 | 473.85 | 414.25 | Upgrade
|
| Gross Profit | 27.99 | 39.07 | 38.94 | 39.39 | 81 | 78.34 | 79.21 | 66.78 | 65.41 | 62.56 | Upgrade
|
| Selling, General & Admin | 38.97 | 34.66 | 27.72 | 40.67 | 62.06 | 51.95 | 52.49 | 46.18 | 39.96 | 35.17 | Upgrade
|
| Research & Development | 8.74 | 7.84 | 6.68 | 7.58 | 11.47 | 12.8 | 9.47 | 7.23 | 6.99 | 7.2 | Upgrade
|
| Other Operating Expenses | 2.08 | 8.36 | 13.36 | 17.01 | 2 | 0 | 2.58 | 34 | 0 | 0 | Upgrade
|
| Operating Expenses | 49.78 | 50.86 | 47.76 | 65.26 | 75.53 | 64.75 | 64.54 | 87.41 | 46.95 | 42.37 | Upgrade
|
| Operating Income | -21.8 | -11.79 | -8.82 | -25.88 | 5.48 | 13.59 | 14.67 | -20.63 | 18.46 | 20.19 | Upgrade
|
| Interest Expense / Income | 17.65 | 15.55 | 8.93 | 4.65 | 5.23 | 1.95 | 1.83 | 1.99 | 1.83 | 1.65 | Upgrade
|
| Other Expense / Income | 59.81 | 94.58 | 20.89 | 16.44 | -1.68 | -3.83 | -1.79 | -3.27 | -4.66 | -11.19 | Upgrade
|
| Pretax Income | -99.26 | -121.93 | -38.64 | -46.97 | 1.93 | 15.47 | 14.63 | -19.35 | 21.29 | 29.73 | Upgrade
|
| Income Tax | 0.31 | -5.21 | -6.35 | -8.77 | 1.52 | -9.36 | 4.04 | -7.7 | 7.75 | 10.58 | Upgrade
|
| Net Income | -99.56 | -116.72 | -32.29 | -38.19 | 0.41 | 24.83 | 10.59 | -11.64 | 13.54 | 19.15 | Upgrade
|
| Net Income Growth | - | - | - | - | -98.34% | 134.46% | - | - | -29.26% | -15.24% | Upgrade
|
| Shares Outstanding (Basic) | 30 | 29 | 29 | 29 | 28 | 28 | 27 | 27 | 27 | 27 | Upgrade
|
| Shares Outstanding (Diluted) | 30 | 29 | 29 | 29 | 29 | 28 | 28 | 27 | 27 | 27 | Upgrade
|
| Shares Change | 1.67% | 0.59% | 0.45% | 1.94% | 2.48% | 0.95% | 2.25% | -1.07% | 0.80% | 1.86% | Upgrade
|
| EPS (Basic) | -3.32 | -3.97 | -1.10 | -1.31 | 0.01 | 0.90 | 0.39 | -0.43 | 0.50 | 0.72 | Upgrade
|
| EPS (Diluted) | -3.32 | -3.97 | -1.10 | -1.31 | 0.01 | 0.89 | 0.38 | -0.43 | 0.50 | 0.71 | Upgrade
|
| EPS Growth | - | - | - | - | -98.88% | 134.21% | - | - | -29.58% | -16.47% | Upgrade
|
| Free Cash Flow | -38.92 | -51.39 | 4.16 | -41.29 | -28.45 | -13.71 | 6.92 | -18.81 | 10.18 | 6.16 | Upgrade
|
| Free Cash Flow Per Share | -1.30 | -1.74 | 0.14 | -1.42 | -1.00 | -0.50 | 0.25 | -0.69 | 0.38 | 0.23 | Upgrade
|
| Gross Margin | 27.10% | 35.11% | 38.60% | 24.61% | 14.53% | 14.94% | 16.86% | 14.00% | 12.13% | 13.12% | Upgrade
|
| Operating Margin | -21.11% | -10.60% | -8.75% | -16.17% | 0.98% | 2.59% | 3.12% | -4.33% | 3.42% | 4.23% | Upgrade
|
| Profit Margin | -96.41% | -104.89% | -32.01% | -23.86% | 0.07% | 4.74% | 2.25% | -2.44% | 2.51% | 4.02% | Upgrade
|
| Free Cash Flow Margin | -37.69% | -46.19% | 4.12% | -25.80% | -5.10% | -2.62% | 1.47% | -3.94% | 1.89% | 1.29% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 78.69% | -60.54% | 27.61% | - | 36.38% | 35.60% | Upgrade
|
| EBITDA | -68.32 | -88.31 | -9.84 | -23.48 | 22.39 | 29.83 | 27.13 | -7.96 | 30.21 | 38.49 | Upgrade
|
| EBITDA Margin | -66.16% | -79.37% | -9.76% | -14.67% | 4.02% | 5.69% | 5.78% | -1.67% | 5.60% | 8.07% | Upgrade
|
| Depreciation & Amortization | 13.29 | 18.06 | 19.87 | 18.84 | 15.23 | 12.41 | 10.68 | 9.4 | 7.09 | 7.11 | Upgrade
|
| EBIT | -81.61 | -106.38 | -29.71 | -42.32 | 7.16 | 17.42 | 16.46 | -17.36 | 23.12 | 31.38 | Upgrade
|
| EBIT Margin | -79.02% | -95.60% | -29.45% | -26.44% | 1.28% | 3.32% | 3.50% | -3.64% | 4.29% | 6.58% | Upgrade
|